Effects of Transdermal Nicotine and Concurrent Smoking on Cognitive Performance in Tobacco-Abstinent Smokers

Experimental and Clinical Psychopharmacology

Volumn 19, Issue 1, 2011, Pages 75-84

  Kleykamp, Bethea A ^a   Jennings, Janine M ^b   Eissenberg, Thomas ^c  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b WAKE FOREST UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Cognition; Nicotine; Performance; Smoking; Tobacco

Indexed keywords

NICOTINE;

ADULT; ARTICLE; CIGARETTE SMOKING; COGNITIVE DEFECT; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOMOTOR ACTIVITY; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TREATMENT OUTCOME; WORKING MEMORY;

ADMINISTRATION, CUTANEOUS; ADULT; ATTENTION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NICOTINE; PSYCHOMOTOR PERFORMANCE; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 79952076003     PISSN: 10641297     EISSN: 19362293     Source Type: Journal    
DOI: 10.1037/a0022417     Document Type: Article

References (61)

1. AhnAllen C.G., Nestor P.G., Shenton M.E., McCarley R.W., Niznikiewicz M.A. Early nicotine withdrawal and transdermal nicotine effects on neurocognitive performance in schizophrenia. Schizophrenia Research 2008, 100:261-269.
2. Atzori G., Lemmonds C.A., Kotler M.L., Durcan M.J., Boyle J. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal. Journal of Clinical Psychopharmacolgy 2008, 28:667-674.
3. Baddeley A.D. Essentials of human memory 1999, Psychology Press, London.
4. Beck A.T., Steer R.A., Brown G.K. Manual for Beck Depression Inventory II (BDI-II) 1996, Psychology Corporation, San Antonio, TX.
5. Bell S.L., Taylor R.C., Singleton E.G., Henningfield J.E., Heishman S.J. Smoking after nicotine deprivation enhances cognitive performance and decreases tobacco craving in drug abusers. Nicotine & Tobacco Research 1999, 1:45-52.
6. Benowitz N.L., Zevin S., Jacob P. Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine. Journal of Pharmacology and Experimental Therapeutics 1998, 287:958-962.
7. Bjornson W., Rand C., Connett J.E., Lindgren P., Nides M., Pope F., O'Hara P. Gender differences in smoking cessation after 3 years in the Lung Health Study. American Journal of Public Health 1995, 85:223-230.
8. Blank M.D., Kleykamp B.A., Jennings J.M., Eissenberg T. Caffeine's influence on nicotine's effects in non-smokers. American Journal of Health Behavior 2007, 31:473-483.
9. Burton S.L., Gitchell J.G., Shiffman S. Use of FDA-approved pharmacologic treatments for tobacco dependence-United States, 1984-1998. Morbidity and Mortality Weekly Report 2000, 49:665-668.
10. Cigarette smoking among adults-United States, 2000. Morbidity and Mortality Weekly Report 2002, 51:642-645. Centers for Disease Control and Prevention.
11. Cigarette smoking among adults and trends in smoking cessation-United States, 2008. Morbidity and Mortality Weekly Report 2009, 58:1227-1232. Centers for Disease Control and Prevention.
12. Cepeda-Benito A., Reynoso J.T., Erath S. Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: Differences between men and women. Journal of Consulting and Clinical Psychology 2004, 72:712-722.
13. Cook M.R., Gerkovich M.M., Graham C., Hoffman S.J., Peterson R.C. Effects of the nicotine patch on performance during the first week of smoking cessation. Nicotine & Tobacco Research 2003, 5:169-180.
14. Coull J.T., Frith C.D., Frackowiak R.S.J., Grasby P.M. A frontoparietal network for rapid visual information processing: A PET study of sustained attention and working memory. Neuropsychologia 1996, 34:1085-1095.
15. Daughton D.M., Fortmann S.P., Glover E.D., Hatsukami D.K., Heatley S.A., Lichtenstein E., Rennard S.I. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Preventative Medicine 1999, 28:113-118.
16. Eddins D., Petro A., Williams P., Cerutti D.T., Levin E.D. Nicotine effects on learning in zebrafish: The role of dopaminergic systems. Psychopharmacology 2009, 2020:103-109.
17. Ernst M., Matochik J.A., Heishman S.J., Van Horn J.D., Jons P.H., Henningfield J.E., London E.D. The effect of nicotine on brain activation during performance on a working memory task. Proceedings of the National Academy of Sciences, USA 2001, 98:4728-4733.
18. Evans S.E., Blank M., Sams C., Weaver M.F., Eissenberg T. Transdermal nicotine-induced tobacco abstinence symptom suppression: Nicotine dose and smokers' gender. Experimental and Clinical Psychopharmacology 2006, 14:121-135.
19. Fan J., McCandliss B.D., Sommer T., Raz A., Posner M.I. Testing the efficiency and independence of attentional networks. Journal of Cognitive Neuroscience 2002, 14:340-347.
20. Fant R.V., Owen L.L., Henningfield J.E. Tobacco use and cessation: Nicotine replacement therapy. Primary Care: Clinics in Office Practice 1999, 26:633-652.
21. Ferguson S.G., Shiffman S., Gwaltney C.J. Does reducing withdrawal severity mediate nicotine patch efficacy? A randomized clinical trial. Journal of Consulting and Clinical Psychology 2006, 74:1153-1161.
22. Foulds J., Stapleton J., Swettenham J., Bell N., McSorely K., Russell M.A.H. Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology 1996, 127:31-38.
23. Grobe J.E., Perkins K.A., Goettler-Good J., Wilson A. Importance of environmental distractors in the effects of nicotine on short-term memory. Experimental and Clinical Psychopharmacology 1998, 6:209-216.
24. Hasenfratz M., Bättig K. Action profiles of smoking and caffeine: Stroop effect, EEG, and peripheral physiology. Pharmacology Biochemistry and Behavior 1992, 42:155-161.
25. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerström K.O. The Fagerström Test for nicotine dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction 1991, 86:1119-1127.
26. Heishman S.J., Taylor R.C., Henningfield J.E. Nicotine and smoking: A review of effects on human performance. Experimental and Clinical Psychopharmacology 1994, 2:345-395.
27. Hughes J.R., Hatsukami D.K., Pickens R.W., Krahn D., Malin S., Luknic A. Effect of nicotine on tobacco withdrawal syndrome. Psychopharmacology 1984, 83:82-87.
28. Hurlburt R.T. Comprehending behavioral statistics 1998, Brooks/Cole, Pacific Grove, CA. 2nd ed.
29. Huynh H.S., Feldt L.S. Estimation of the Box correction for degrees of freedom from sample data in randomized block and split-plot designs. Journal of Statistics Education 1976, 1:69-82.
30. Kleykamp B.A., Jennings J.M., Blank M.D., Eissenberg T. The effects of nicotine on specific cognitive processes in never-smokers. Psychology of Addictive Behaviors 2005, 19:433-438.
31. Kleykamp, B. A., Jennings, J. M., Sams, C. L., Shaffer, D., Austin, J., Gray, J., Eissenberg, T. (2007, February). The effects of smoking-related stimuli on cognitive performance. Presentation at 13th Annual Meeting of the Society for Research on Nicotine and Tobacco, Austin, TX.
32. Kleykamp B.A., Jennings J.M., Sam C., Weaver M., Eissenberg T. The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men. Experimental and Clinical Psychopharmacology 2008, 16:99-112.
33. Knott V., Bosman M., Mahoney C., Ilivitsky V., Quirt K. Transdermal nicotine: Single dose effects on mood, EEG, performance, and event-related potentials. Pharmacology Biochemistry and Behavior 1999, 63:253-261.
34. Levin E.D., McClernon F.J., Rezvani A.H. Nicotinic effects on cognitive function: Behavioural characterization, pharmacological specification, and anatomic localization. Psychopharmacology 2006, 184:523-539.
35. Mancuso G., Andres P., Ansseau M., Tirelli E. Effects of nicotine administered via a transdermal delivery system on vigilance: A repeated measure study. Psychopharmacology 1999, 142:18-23.
36. Mancuso G., Warburton D.M., Melen M., Sherwood N., Tirelli E. Selective effects of nicotine on attentional processes. Psychopharmacology 1999, 146:199-204.
37. McLeod D.R., Griffiths R.R., Bigelow G.E., Yingling J. An automated version of the digit symbol substitution test (DSST). Behavioral Research Methods and Instruments 1982, 14:463-466.
38. Myers C.S., Taylor R.C., Moolchan E.T., Heishman S.J. Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray. Neuropsychopharmacology 2008, 33:588-598.
39. Nemeth-Coslett R., Henningfield J.E., O'Keefe M.K., Griffiths R.R. Nicotine gum: Dose-related effects on cigarette smoking and subjective effects. Psychopharmacology 1987, 92:424-430.
40. Parrott A.C., Craig D. Cigarette smoking and nicotine gum (0, 2, and 4 mg) effects upon four visual attention tasks. Biological Psychology 1992, 25:34-43.
41. Parrott A.C., Roberts G. Smoking deprivation and cigarette reinstatement: Effects upon visual attention. Psychopharmacology 1991, 5:404-409.
42. Patterson F., Jepson C., Loughead J., Perkins K., Strasser A.A., Siegel S., Lerman C. Working memory deficits predict short-term smoking resumption following brief abstinence. Drug and Alcohol Dependence 2010, 106:61-64.
43. Perkins K., Sayette M., Conklin C., Caggiula A. Placebo effects of tobacco smoking and other nicotine intake. Nicotine & Tobacco Research 2003, 5:695-709.
44. Perkins K.A., Scott J. Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine & Tobacco Research 2008, 10:1245-1250.
45. Pickworth W.B., Fant R.V., Butschky M.F., Henningfield J.E. Effects of transdermal nicotine delivery on measures of acute nicotine withdrawal. Journal of Pharmacology and Experimental Therapeutics 1996, 279:450-456.
46. Poorthuis R.B., Goriounova N.A., Couey J.J., Mansvelder H.D. Nicotinic actions on neuronal networks on cognition: General principles and long-term consequences. Biochemical Pharmacology 2009, 78:668-676.
47. Posner M.I., Peterson S.E. The attention system of the human brain. Annual Review of Neuroscience 1990, 13:25-42.
48. Richmond R., Kehoe L. Ten-year survival outcome of the nicotine transdermal patch with cognitive behavioural therapy. Australian and New Zealand Journal of Public Health 2007, 31:282-285.
49. Richmond R., Kehoe L., de Almeida Neto A. Three year continuous abstinence in a smoking cessation study using the nicotine transdermal patch. Heart 1997, 78:617-618.
50. Rose J.E. Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology 2006, 184:274-285.
51. Rukstalis M., Jepson C., Patterson F., Lerman C. Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy. Journal of Substance Abuse Treatment 2005, 28:297-304.
52. Sherwood N. Nicotine and psychomotor performance. Human Psychopharmacology 1993, 8:155-184.
53. Sherwood N., Kerr J.S., Hindmarch I. Psychomotor performance in smokers following single and repeated doses of nicotine gum. Psychopharmacology 1992, 108:432-436.
54. Shiffman S., Fant R.V., Buchhalter A.R., Gitchell J.G., Henningfield J.E. Nicotine delivery systems. Expert Opinion on Drug Delivery 2005, 2:563-577.
55. Snyder F.R., Davis F.C., Henningfield J.E. The tobacco withdrawal syndrome: Performance decrements assessed on a computerized test battery. Drug and Alcohol Dependence 1989, 23:259-266.
56. Snyder F.R., Henningfield J.E. Effects of nicotine administration following 12h of tobacco deprivation: Assessment on computerized performance tasks. Psychopharmacology 1989, 97:17-22.
57. Swan G.E., Jack L.M., Ward M.M. Subgroups of smokers with different success rates after use of transdermal nicotine. Addiction 1997, 92:207-218.
58. Tonnesen P., Norregaard J., Simonsen K., Sawe U. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. New England Journal of Medicine 1991, 325:311-315.
59. Trimmel M., Wittberger S. Effects of transdermally administered nicotine on aspects of attention, task load, and mood in women and men. Pharmacology Biochemistry and Behavior 2004, 78:639-645.
60. Warburton D.M., Mancuso G. Evaluation of the information processing and mood effects of a transdermal nicotine patch. Psychopharmacology 1998, 135:305-310.
61. Wesnes K., Warburton D.M., Matz B. Effects of nicotine on stimulus sensitivity and response bias in a visual vigilance task. Neuropsychobiology 1983, 9:41-44.